Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

8 Biotech Events To Anticipate This Year: Part One
Seeking Alpha
Tuesday, April 8, 2014 - 9:46am
tags:
Zohydro, Zogenix, Zybrestat, Oxigene, Arikayce, Insmed, obeticholic acid, Intercept Pharmaceuticals
Zogenix Seeks to Stop Massachusetts Ban on Painkiller
Bloomberg
Tuesday, April 8, 2014 - 9:44am
tags:
Zogenix, Massachusetts, Zohydro, hydrocodone
Can J&J's Pharma Segment Deliver Meaningful Growth?
Motley Fool
Tuesday, April 8, 2014 - 9:43am
tags:
JNJ
Intuitive Surgical's Robots Don't Play Well With Each Other and Docs are Mad
TheStreet.com
Tuesday, April 8, 2014 - 9:41am
tags:
Intuitive Surgical, physicians, devices, Da Vinci Surgical System
Alkermes' schizophrenia drug meets main goal of late-stage study
Yahoo/Reuters
Tuesday, April 8, 2014 - 9:04am
tags:
Alkermes, schizophrenia, aripiprazole lauroxil
US jury hits Takeda, Eli Lilly with $9 bln penalty
Yahoo/AP
Tuesday, April 8, 2014 - 8:56am
tags:
Takeda, Actos, Eli Lilly, diabetes
Oncolytics Biotech reports tumor stabilization or shrinkage in REOLYSIN study
The Fly on the Wall
Tuesday, April 8, 2014 - 8:11am
tags:
Oncolytics, Reolysin, head and neck cancer
Disclosing Doctors' Medicare Pay Might Be 'Pretty Damning'
Bloomberg Businessweek
Tuesday, April 8, 2014 - 8:08am
tags:
Medicare, physicians
Europe backs more transparent, simpler clinical trial rules
Reuters
Monday, April 7, 2014 - 5:10pm
tags:
Europe, clinical trials, transparency
One Thing Drug Companies Won’t Do On Social Media
WSJ Online
Monday, April 7, 2014 - 5:09pm
tags:
social media, clinical trials
Biogen Idec May Have Seeds For Next-Gen MS Drugs
Investors.com
Monday, April 7, 2014 - 5:08pm
tags:
MS, Biogen Idec, multiple sclerosis, BIIB-061, remylination, Tecfidera
Takeda Showed Disregard in Handling Diabetes Drug, Jury Told
Bloomberg
Monday, April 7, 2014 - 5:07pm
tags:
Takeda, diabetes, Actos
GlaxoSmithKline Faces Bribery Allegations Yet Again, This Time in Iraq
Wall St Cheat Sheet
Monday, April 7, 2014 - 5:04pm
tags:
GSK, Iraq, China, bribery
If Glaxo's CEO wants to be Mr. Clean, he needs to pick up a broom
Fierce Pharma Marketing
Monday, April 7, 2014 - 1:04pm
tags:
GSK, Pharma CEOs, Andrew Witty
Hologic, GE, PositiveID land near $100M in Defense contracts
Mass Device
Monday, April 7, 2014 - 1:00pm
tags:
General Electric, PositiveID, devices, Hologic, defense contracts
Immunomedics reports results from three IMMU-130 phase I trials
Yahoo/Fly on the Wall
Monday, April 7, 2014 - 12:59pm
tags:
Immunomedics, IMMU-130, colorectal cancer
Boehringer Ingelheim's Oral Anticoagulant Gains New Indication
Forbes
Monday, April 7, 2014 - 12:57pm
tags:
Boehringer Ingelheim, anticlotting, Pradaxa, deep venous thrombosis, DVT, pulmonary embolism
FDA Keeps Driving Up Future Cost of Inhalable Insulin
Yahoo/247WallStreet
Monday, April 7, 2014 - 12:56pm
tags:
FDA, inhaled insulin, diabetes, Afrezza, MannKind
A Physician-Businessman's Views Of Gilead, With Emphasis On Sovaldi
Seeking Alpha
Monday, April 7, 2014 - 12:54pm
tags:
physicians, Sovaldi, Gilead Sciences, hepatitis C
FDA Breakthrough Therapy Designation For Novartis' Bexsero Vaccine To Prevent Meningitis B
Forbes
Monday, April 7, 2014 - 12:53pm
tags:
FDA, Novartis, Bexsero, vaccines, breakthrough therapies, meningitis B

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.